Skip to main content
. 2023 Jul 30;7(18):5540–5548. doi: 10.1182/bloodadvances.2023010312

Table 2.

Univariate and multivariate Cox regression analysis dependent on blast count (top) and TP53 state (bottom)

Univariate
Multivariate
P value HR P value HR
Total cohort
 TP53 single hit .043 1.4 .003 1.6
 TP53 double hit < .001 4.9 < .001 3.9
 Blast count (<5%, ≥5%) < .001 1.9 < .001 1.8
 Complex karyotype < .001 3.2 .047 1.3
MDS with <5% blasts
 TP53 single hit .018 1.7 .021 1.7
 TP53 double hit < .001 4.9 .041 2.2
 Complex karyotype < .001 7.0 < .001 5.2
MDS with ≥5% but <10% blasts
 TP53 single hit .028 2.2 .026 2.3
 TP53 double hit < .001 12.1 < .001 9.2
 Complex karyotype < .001 4.1 ns
MDS with ≥10% but <20% blasts
 TP53 single hit n.s.
 TP53 double hit < .001 5.6 .004 4.6
 Complex karyotype < .001 3.2 ns
AML
 TP53 single hit .039 1.5 .044 1.6
 TP53 double hit < .001 4.4 < .001 4.2
 Complex karyotype < .001 2.6 n.s.
Univariate
Multivariate
P value HR P value HR
Without TP53 alteration
 Blast count (<5%, ≥5%) < .001 1.8 < .001 1.8
 Complex karyotype .038 1.6 ns
TP53 single hit
 Blast count (<5%, ≥5%) .007 2.2 .013 2.2
 Complex karyotype .035 1.5 n.s.
TP53 double hit
 Blast count (<5%, ≥5%) .008 2.9 .008 2.9
 Complex karyotype ns

ns, not significant.